Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

Peter Libby MD Advisory Board

Paul D. Thompson MD Advisory Board

James E. Udelson MD Advisory Board

See All Experts

Published in Cardiology

Journal Scan / Review · November 01, 2021

Combination Lipid-Lowering Therapy in Very High–Risk Patients

European Heart Journal

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Article Citation

European Heart Journal

Combination lipid-lowering therapy as first-line strategy in very high-risk patients

Eur Heart J 2021 Oct 12;[EPub Ahead of Print], KK Ray, LF Reeskamp, U Laufs, M Banach, F Mach, LS Tokgözoğlu, DL Connolly, AJ Gerrits, ESG Stroes, L Masana, JJP Kastelein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Combination Lipid-Lowering Therapy in Very High–Risk Patients

Additional Info

Combination lipid-lowering therapy as first-line strategy in very high-risk patients

Further Reading

Final Note From the Cardiology Board

Effect of Catheter Ablation of Electrical Storm on Survival

Transesophageal 3D Echocardiographic Guidance for Pacemaker Lead Placement

Echocardiographic Evaluation of Chronic Aortic Regurgitation: Comparison With CMR and Implications for Guideline Recommendations

CTCA Prior to Invasive Coronary Angiography in Patients With Previous Bypass Surgery

Genetic Basis of Early Onset and Progression of Type 2 Diabetes in South Asians

Mediterranean Diet, Neutrophil Count, and Carotid Intima-Media Thickness in Secondary Prevention

Post-MI Outcomes After First-Line Ablation in Patients With Tolerated VT and an LVEF >35%

Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome

Development and Evaluation of a Comprehensive Prediction Model for Incident Coronary Heart Disease Using Genetic, Social, and Lifestyle–Psychological Factors

Long-Term Prognosis of Coronary Aneurysms

Recently Updated